American Century Companies’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-703,044
| Closed | -$5.79M | – | 2374 |
|
2021
Q2 | $5.79M | Buy |
703,044
+1,255
| +0.2% | +$10.3K | ﹤0.01% | 955 |
|
2021
Q1 | $6.28M | Buy |
701,789
+52,081
| +8% | +$466K | ﹤0.01% | 876 |
|
2020
Q4 | $7.5M | Buy |
649,708
+53,509
| +9% | +$618K | 0.01% | 812 |
|
2020
Q3 | $6.21M | Sell |
596,199
-51,671
| -8% | -$538K | 0.01% | 781 |
|
2020
Q2 | $8.52M | Buy |
647,870
+350,744
| +118% | +$4.61M | 0.01% | 715 |
|
2020
Q1 | $2.34M | Sell |
297,126
-38,938
| -12% | -$306K | ﹤0.01% | 826 |
|
2019
Q4 | $6.96M | Buy |
336,064
+112,380
| +50% | +$2.33M | 0.01% | 756 |
|
2019
Q3 | $3.07M | Buy |
223,684
+55,212
| +33% | +$757K | ﹤0.01% | 895 |
|
2019
Q2 | $2.07M | Sell |
168,472
-356
| -0.2% | -$4.38K | ﹤0.01% | 1017 |
|
2019
Q1 | $2.11M | Sell |
168,828
-6,952
| -4% | -$86.8K | ﹤0.01% | 984 |
|
2018
Q4 | $1.99M | Buy |
175,780
+3,666
| +2% | +$41.5K | ﹤0.01% | 975 |
|
2018
Q3 | $3.22M | Buy |
172,114
+41,752
| +32% | +$781K | ﹤0.01% | 942 |
|
2018
Q2 | $3.37M | Buy |
130,362
+336
| +0.3% | +$8.69K | ﹤0.01% | 927 |
|
2018
Q1 | $2.91M | Buy |
130,026
+14,517
| +13% | +$325K | ﹤0.01% | 941 |
|
2017
Q4 | $2.89M | Buy |
115,509
+7,483
| +7% | +$187K | ﹤0.01% | 949 |
|
2017
Q3 | $2.61M | Buy |
108,026
+724
| +0.7% | +$17.5K | ﹤0.01% | 994 |
|
2017
Q2 | $2.17M | Sell |
107,302
-990
| -0.9% | -$20K | ﹤0.01% | 1022 |
|
2017
Q1 | $2.91M | Sell |
108,292
-1,469
| -1% | -$39.5K | ﹤0.01% | 986 |
|
2016
Q4 | $2.09M | Buy |
109,761
+27,499
| +33% | +$523K | ﹤0.01% | 1031 |
|
2016
Q3 | $1.61M | Buy |
+82,262
| New | +$1.61M | ﹤0.01% | 1091 |
|